HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indicaxanthin from cactus pear fruit exerts anti-inflammatory effects in carrageenin-induced rat pleurisy.

Abstract
Nutritional research has shifted recently from alleviating nutrient deficiencies to chronic disease prevention. We investigated the activity of indicaxanthin, a bioavailable phytochemical of the betalain class from the edible fruit of Opuntia ficus-indica (L. Miller) in a rat model of acute inflammation. Rat pleurisy was achieved by injection of 0.2 mL of λ-carrageenin in the pleural cavity, and rats were killed 4, 24, and 48 h later; exudates were collected to analyze inflammatory parameters, such as nitric oxide (NO), prostaglandin E(2) (PGE(2)), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α); cells recruited in pleura were analyzed for cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) expression, and nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) activation. Indicaxanthin (0.5, 1, or 2 μmol/kg), given orally before carrageenin, time- and dose-dependently, reduced the exudate volume (up to 70%) and the number of leukocytes recruited in the pleural cavity (up to 95%) at 24 h. Pretreatment with indicaxanthin at 2 μmol/kg inhibited the carrageenin-induced release of PGE(2) (91.4%), NO (67.7%), IL-1β (53.6%), and TNF-α (71.1%), and caused a decrease of IL-1β (34.5%), TNF-α (81.6%), iNOS (75.2%), and COX2 (87.7%) mRNA, as well as iNOS (71.9%) and COX-2 (65.9%) protein expression, in the recruited leukocytes. Indicaxanthin inhibited time- and dose- dependently the activation of NF-κB, a key transcription factor in the whole inflammatory cascade. A pharmacokinetic study with a single 2 μmol/kg oral administration showed a maximum 0.22 ± 0.02 μmol/L (n = 15) plasma concentration of indicaxanthin, with a half-life of 1.15 ± 0.11 h. When considering the high bioavailability of indicaxanthin in humans, our findings suggest that this dietary pigment has the potential to improve health and prevent inflammation-based disorders.
AuthorsMario Allegra, Angela Ianaro, Mariaroberta Tersigni, Elisabetta Panza, Luisa Tesoriere, Maria Antonia Livrea
JournalThe Journal of nutrition (J Nutr) Vol. 144 Issue 2 Pg. 185-92 (Feb 2014) ISSN: 1541-6100 [Electronic] United States
PMID24306215 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Betaxanthins
  • Inflammation Mediators
  • Plant Extracts
  • Pyridines
  • RNA, Messenger
  • indicaxanthin
  • Carrageenan
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Betaxanthins (pharmacology, therapeutic use)
  • Carrageenan
  • Disease Models, Animal
  • Fruit (chemistry)
  • Inflammation (chemically induced, diet therapy, drug therapy, metabolism)
  • Inflammation Mediators (metabolism)
  • Leukocytes (metabolism)
  • Male
  • Opuntia (chemistry)
  • Phytotherapy
  • Plant Extracts (pharmacology, therapeutic use)
  • Pleural Cavity (drug effects, metabolism)
  • Pleurisy (chemically induced, diet therapy, drug therapy, metabolism)
  • Pyridines (pharmacology, therapeutic use)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: